Programs, populations, and payments verified via SAMHSA.
- Level of care
- IOP · MAT · Dual Dx · Telehealth
- Service settings
- Outpatient, Intensive outpatient treatment, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment
- Therapy approaches
- Anger management, Brief intervention, Cognitive behavioral therapy, Contingency management/motivational incentives, Motivational interviewing, Relapse prevention, Substance use disorder counseling, Telemedicine/telehealth therapy
- Special populations
- Adolescents, Young adults, Adult women, Adult men, Clients with co-occurring mental and substance use disorders, Clients with co-occurring pain and substance use disorders, Clients with HIV or AIDS, Clients who have experienced intimate partner violence, domestic violence, Clients who have experienced trauma
- Medications used
- Acamprosate (Campral®), Disulfiram, Buprenorphine sub-dermal implant, Buprenorphine with naloxone, Buprenorphine without naloxone, Buprenorphine (extended-release, injectable), Naltrexone (oral), Naltrexone (extended-release, injectable), Medications for HIV treatment, Medications for Hepatitis C treatment + 4 more
- Recovery supports
- Self-help groups, Housing services, Assistance with obtaining social services, Mentoring/peer support
- Facility operation
- Private non-profit organization
